North Carolina Biotechnology

U.S. based companies hold rights to most of the world’s rights on new medicines and holds thousands of new products currently being developed. As of 2012, the industry helps support almost 3.4 million jobs in the U.S. economy. It is also one of the most heavily R&D based industries in the world. In the United States, the environment for pharmaceuticals is much friendlier than other countries around the world in terms of pricing ability and regulations. Both the Pharmaceutical and Biotechnology industries have experienced significant growth in the past year with year-over-year increases of 13.02% and 34.69% respectively. It is an even more striking when looking at the past five years considering both have beat out the S&P 500 with pharmaceuticals increasing an additional 31.44% and the biotechnology sector besting an astonishing 269.3% more return than the

Cynthia Robbins-Roth is a strategic planner and business consultant to the biotechnology industry, named one of the Top 25 Biotech All-Stars by popular business magazine Forbes. Her book, published in year 2000, provides a broad overview of many biotech topics and draws upon her experience and skill as a keen businesswoman. The engaging and informative work initially details the establishment and growth of the biotechnology industry, as well as its historical origins and information on key players in its founding. Throughout her account of this “dynamic” industry’s early struggles, great successes, and current difficulties, Robbins-Roth presents her opinion of the industry’s current viability and hopes of the future product pipeline. Robbins-Roth predicts a revolutionary change in health management and treatment, which combined with the growing aged population, will produce sufficient demand to propel the biotechnology industry past the well-established small molecule pharmaceutical companies. She asserts that the biotechnology companies will emerge as the leaders in the world’s medical research and development. Robbins-Roth further explains the intricacies of financing a biotechnology venture, the necessity of efficient risk management, and the difficulty of selling an idea to non-scientist investors.

In 2017 the growth rate of the population in Guilford county was up 0.73% from the previous year, while Forsyth’s rate of growth was higher at 0.95%. ( cite world population) The location of both counties makes them attractive options for those who want to be close to larger cities, such as, Charlotte and Raleigh but have no desire to live in rural areas. These counties had the allure of being a manufacturing hub. Textile plants like Cone Mills, R.J. Reynolds tobacco plant, Western Electric with their electronic engineering facility, and the expansion of the High Point furniture market allowed Guilford and Forsyth to flourish into the 90s. Many of those people chose to stay in the area and learn a different trade after the manufacturing plants moved overseas. * maybe\Now there are new industries on

Keith R. Shneider has explained where and what Genetically Modified Foods are. Biotechnology and Genetic Modification and are mutually involved in creating genetically modified foods (GMF). The general term, Biotechnology means that it uses organisms or components of the organism to make products. Genetic modification adjusts the genetic make-up of organisms with the use of a special set of technology. In order for the organism’s results to be called genetically modified, it has to go through the recombinant DNA technology, which combines genes form different organisms. Medicine, food, food ingredients, feeds, and fibers are products

Biotechnology is the use of living systems and organisms to develop useful products and is a technological application that uses living organisms or systems. There is much controversy in the use of these systems because of possible health and environmental effects. One of the most widely used products of biotechnology is genetically modified (GM) crops. These are crops that have a specific combination of genetic material that is acquired through certain biotechnological processes or genetic engineering. Many crops have been subject to these genetic modifications such as: alfalfa, cotton, flax, rice, tobacco, tomatoes, and wheat. Many people are on various sides of the spectrum of being for the alteration of these crops or strongly against it.

Economy: An expanding international commitment to free trade among countries has internationalized the market for goods; people have access to goods that were previously out of reach. Finally, in addition to the exchange of goods across borders, traders move billions of dollars daily with the click of a mouse. Some countries have been helped by the newly emerging economic order because they have the resources to expand production worldwide and to create goods that are in demand internationally. On the other hand, some countries and individuals have been hurt because they are not able to compete with the strongest producers internationally. The United States is one of the world's leading exporters and maintains a lead in many of the future's most promising industries, including biotechnology, space technology, and computer software. U.S. corporations have sought a competitive edge by taking advantage of cheap labor in Latin America and Asia.

the economy so much because of the potential applications it could offer other than just as a

Biotech companies’ values are primarily driven by intellectual property, they do not need to rely much on their suppliers. These companies also have relatively easy access to sources of raw materials (such as chemicals), scientific tools, computers and testing equipment.

There are several rewards to consider with expansion of Biocon. Currently in India, there is a growing market for contract research organization and the growth of Biocon falls right within this opportunity. The growth is expected to last for more than few years with a rate that looks promising. Clinigene is expected to reap revenues much higher than the current Biocon and Syngene combined (Kalegaonkar A., Nov 4, 2008). It will take clinical studies to a higher level with better options in terms of drug manufacturing. With other countries ready to outsource the service of clinical studies, Clinigene’s future looks bright.

The process of life has always intrigued me. From the abundance of technology being created every day to new cures battling new diseases, the world of biology is continually changing. I have always dreamt of being part of a field whose main purpose is to help others and to improve the world around us; to me that is Biotechnology. Biotechnology is the field for future innovations that benefits an individual, but also the society.

Biotechnology is a broad term. Basically, it is the “tools and techniques [opening] new research avenues for discovering how healthy bodies work and what goes wrong when problems arise”(Siedler para. 1). It covers controversial technology and procedure, like genetic engineering and gene therapy. It is controversial because it can affect everyone(Jeremy para. 16). As a consequence, the development of biotechnology has been a “slow, quiet progress”(Kirsner para. 3) because society may or may not recognize the repercussion of it. However, scientist like Smith- a previous chief for the Cambridge biotech company, Genzyme- continues to develop biotechnology(para. 1). Because biotechnology can be controversial, yet scientist continues to develop it;

The competition with the food industry, which has strong expertise in large-scale manufacturing and global logistics that can reach mass markets of consumers. However, the companies in the food industry do not pursue today advanced research expertise.

Biotechnology is the technology based on the science of cellular and biomolecular processes. The processes develop technologies and products that help improve the lives of people and even affect the health of our environment. Biotechnology uses cellular and biomolecular processes by using molecular mechanisms by which genetic and metabolic processes occur in plant, animal, and microbial organisms. By using this technology, it provides breakthrough products and technologies to combat debilitating and rare diseases, reduce our environment footprint, feeding the hungry, uses less energy and cleaner energy, and has safer and cleaner and more efficient industrial manufacturing processes. The many factors they are driven to prevent in our environment overall affects our human health. Genentech provides products in the areas of immunology, oncology, and disorders of tissue growth and repair. A familiar life-threatening disease is cancer. Whether it is melanoma, ovarian cancer, or

The challenge that society faces today, is eating a more mainstream, middle class diet while also managing the affordability of food production and food purchase. Selective breeding is a way for scientists to select for certain genetics that increase plant health and yields. Whereas, biotechnology allows for an expansion of acreage to be utilized for production of food crops like corn, soybeans, wheat, etc.

Biotechnology is defined as the application of biological processes for industrial and other purposes. In its purest form, biotechnology refers to the use of living organisms or their products to modify human health and the human environment. Biotechnology can be applied in many different fields, such as medicine, food, agriculture, genetics and many more. Biotechnology is also commonly associated with landmark break-throughs in new medical therapies to treat diabetes, hepatitis B, hepatitis C, cancers, arthiritis, etc.